I
am deeply interested in the subject of glycemia/ HbA 1c relationships, underlying mechanisms, and impact on the assessment of glycemic control and diabetes prevalence. In the article by Soranzo et al.
(1) published in Diabetes, the abstract indicates that adjusted HbA 1c would imply the reclassification of about 2% of the subjects in a general Caucasian population.
The table provided in Fig. 3 of that article is displayed below (Table 1) At the population level, should diabetes diagnosis be performed using HbA 1c , adjustment for 7 single nucleotide polymorphisms, would imply a net reclassification of 28 out of 10,110 subjects, an absolute difference in new diagnosis of 20.27% (3.15-3.42%) and a relative reduction of 27.9% (20.27/3.42) 3 100.
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